Blue Hope Research Award
The Colon Cancer Alliance knows that a proactive approach is vital to knocking colon cancer out of the top three cancer killers. Scientific research is among the best ways we can go on the offensive against this disease. That’s why we’ve launched the Blue Hope Research Award. This one-year fellowship provides vital resources and funding to some of the brightest investigators focusing on colon cancer research.
COLON CANCER ALLIANCE-AACR FELLOWSHIP FOR BIOMARKER RESEARCH
In 2014, we’re partnering with the American Association for Cancer Research (AACR) to support biomarker research focused on the prevention or treatment of colon cancer. These genetic indicators are the key to unlocking more personalized care, ultimately saving more lives.
Breaking Down Biomarkers
Scientists are finding that each person’s cancer is unique. So although two people may both be diagnosed with colon cancer, they may react to the same treatment in drastically different ways.
The future of cancer study and treatment is going to be about matching the right therapies – the ones we have stronger evidence will work – with the right individual. It’s about developing personalized medicine.
That’s why scientists are now looking more intensely at biomarkers. When time is of the essence, they can help pave the road to the most effective and efficient treatment plan. Biomarkers can show if you will be a good candidate for surgery, what side effects you’ll have or even whether you’ll be successful on a chemotherapy drug.
How You Can Help
We’re looking for sponsors and donors to support this and other critical research initiatives. To learn more, contact Nicole Sheahan, Corporate Outreach and Fundraising Director, at (202) 628-0123 ext. 103 or email@example.com.